The Addition of Neoadjuvant Pertuzumab for the Treatment of Her2+ Breast Cancer: a Cost Estimate with Real-World Data
AuthID
P-00V-DVY
P-00V-DVY
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service